Achieve Life Sciences/$ACHV
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Achieve Life Sciences
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Ticker
$ACHV
Sector
Primary listing
Employees
25
Headquarters
Website
ACHV Metrics
BasicAdvanced
$235M
-
-$1.35
-
-
Price and volume
Market cap
$235M
52-week high
$5.78
52-week low
$1.84
Average daily volume
1.8M
Financial strength
Current ratio
6.04
Quick ratio
5.806
Long term debt to equity
25.804
Total debt to equity
29.561
Interest coverage (TTM)
-24.01%
Profitability
EBITDA (TTM)
-52.116
Management effectiveness
Return on assets (TTM)
-65.45%
Return on equity (TTM)
-161.08%
Valuation
Price to book
6.97
Price to tangible book (TTM)
7.37
Growth
Earnings per share change (TTM)
17.75%
3-year earnings per share growth (CAGR)
-30.37%
What the Analysts think about ACHV
Analyst ratings (Buy, Hold, Sell) for Achieve Life Sciences stock.
ACHV Financial Performance
Revenues and expenses
ACHV Earnings Performance
Company profitability
ACHV News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Achieve Life Sciences stock?
Achieve Life Sciences (ACHV) has a market cap of $235M as of November 09, 2025.
What is the P/E ratio for Achieve Life Sciences stock?
The price to earnings (P/E) ratio for Achieve Life Sciences (ACHV) stock is 0 as of November 09, 2025.
Does Achieve Life Sciences stock pay dividends?
No, Achieve Life Sciences (ACHV) stock does not pay dividends to its shareholders as of November 09, 2025.
When is the next Achieve Life Sciences dividend payment date?
Achieve Life Sciences (ACHV) stock does not pay dividends to its shareholders.
What is the beta indicator for Achieve Life Sciences?
Achieve Life Sciences (ACHV) does not currently have a Beta indicator.